News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BASi (BASI) Announces Compliance With NASDAQ Capital Market Requirements



4/16/2010 11:22:16 AM

WEST LAFAYETTE, IN--(Marketwire - April 15, 2010) - Bioanalytical Systems, Inc. (NASDAQ: BASI) announced today, as a result of having closing bid prices in excess of $1.00 per share for ten business days on the NASDAQ, that it is now in compliance with continued listing requirements of the NASDAQ Capital Market.

The Company had previously been informed by the NASDAQ Capital Market that it did not meet minimum bid price per share requirements. As a result of an increase in the market value of its stock, the Company is now in compliance with the Capital Market requirements.

BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASInc.com for more information about BASi.



Read at BioSpace.com


comments powered by Disqus
BASi
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES